Home Healthcare IT Pharmacovigilance and Drug Safety Software Market Size, Top Share, Forecast to 2032

Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality (Case data collection and management, Adverse event reporting and analysis, Signal detection and other safety risk assessment), By Delivery Mode (On Premise, On Demand), By End Use (Healthcare Companies, CROs/BPOs/PV service providers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI283DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Pharmacovigilance and Drug Safety Software Market Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Functionality
        1. Introduction
          1. Functionality By Value
        2. Case data collection and management
          1. By Value
        3. Adverse event reporting and analysis
          1. By Value
        4. Signal detection and other safety risk assessment
          1. By Value
      2. By Delivery Mode
        1. Introduction
          1. Delivery Mode By Value
        2. On Premise
          1. By Value
        3. On Demand
          1. By Value
      3. By End Use
        1. Introduction
          1. End Use By Value
        2. Healthcare Companies
          1. By Value
        3. CROs/BPOs/PV service providers
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Functionality
        1. Introduction
          1. Functionality By Value
        2. Case data collection and management
          1. By Value
        3. Adverse event reporting and analysis
          1. By Value
        4. Signal detection and other safety risk assessment
          1. By Value
      2. By Delivery Mode
        1. Introduction
          1. Delivery Mode By Value
        2. On Premise
          1. By Value
        3. On Demand
          1. By Value
      3. By End Use
        1. Introduction
          1. End Use By Value
        2. Healthcare Companies
          1. By Value
        3. CROs/BPOs/PV service providers
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Functionality
        1. Introduction
          1. Functionality By Value
        2. Case data collection and management
          1. By Value
        3. Adverse event reporting and analysis
          1. By Value
        4. Signal detection and other safety risk assessment
          1. By Value
      2. By Delivery Mode
        1. Introduction
          1. Delivery Mode By Value
        2. On Premise
          1. By Value
        3. On Demand
          1. By Value
      3. By End Use
        1. Introduction
          1. End Use By Value
        2. Healthcare Companies
          1. By Value
        3. CROs/BPOs/PV service providers
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Functionality
        1. Introduction
          1. Functionality By Value
        2. Case data collection and management
          1. By Value
        3. Adverse event reporting and analysis
          1. By Value
        4. Signal detection and other safety risk assessment
          1. By Value
      2. By Delivery Mode
        1. Introduction
          1. Delivery Mode By Value
        2. On Premise
          1. By Value
        3. On Demand
          1. By Value
      3. By End Use
        1. Introduction
          1. End Use By Value
        2. Healthcare Companies
          1. By Value
        3. CROs/BPOs/PV service providers
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Functionality
      1. Introduction
        1. Functionality By Value
      2. Case data collection and management
        1. By Value
      3. Adverse event reporting and analysis
        1. By Value
      4. Signal detection and other safety risk assessment
        1. By Value
    3. By Delivery Mode
      1. Introduction
        1. Delivery Mode By Value
      2. On Premise
        1. By Value
      3. On Demand
        1. By Value
    4. By End Use
      1. Introduction
        1. End Use By Value
      2. Healthcare Companies
        1. By Value
      3. CROs/BPOs/PV service providers
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Functionality
        1. Introduction
          1. Functionality By Value
        2. Case data collection and management
          1. By Value
        3. Adverse event reporting and analysis
          1. By Value
        4. Signal detection and other safety risk assessment
          1. By Value
      2. By Delivery Mode
        1. Introduction
          1. Delivery Mode By Value
        2. On Premise
          1. By Value
        3. On Demand
          1. By Value
      3. By End Use
        1. Introduction
          1. End Use By Value
        2. Healthcare Companies
          1. By Value
        3. CROs/BPOs/PV service providers
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Pharmacovigilance and Drug Safety Software Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. ArisGlobal
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Ab Cube
    3. Ennov Solutions Inc.
    4. Extedo GmbH
    5. Online Business Applications Inc.
    6. Oracle Corporation
    7. Sparta Systems Inc.
    8. Sarjen Systems Pvt Ltd
    9. United BioSource Corporation
    10. Max Application
    11. Veeva Systems
    12. APCER life sciences
    13. Phase Forward
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :